• Envoy Medical reached the six-month follow-up milestone in its pivotal trial of the fully implanted Acclaim cochlear implant, marking data collection’s halfway point.
• Twelve-month follow-up visits remain on track for completion by early Q2 2027.
• Final clinical results are expected in the last FDA premarket approval application module by the end of Q2 2027.
• Two of four planned application modules have been submitted, with a potential FDA decision in late 2027 or early 2028.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610200830NEWSFILECNPR____20261020_319914_1) on October 20, 2026, and is solely responsible for the information contained therein.